title: Mass eradication of Helicobacter pylori: feasible and advisable?
authors.affiliation: Universidade Federal do Rio Grande do Sul, School of Medicine, Porto Alegre, Brazil. lemazzoleni@yahoo.com.br
authors.forename: Luiz Edmundo
authors.initials: LE
authors.lastname: Mazzoleni
authors.forename: Carlos Fernando
authors.initials: CF
authors.lastname: Francesconi
authors.forename: Guilherme Becker
authors.initials: GB
authors.lastname: Sander
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage; D000658:Amoxicillin / Q000008:administration & dosage / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D017291:Clarithromycin / Q000008:administration & dosage / Q000009:adverse effects; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D016568:Drugs, Generic; D005240:Feasibility Studies; D005260:Female; D006291:Health Policy / Q000639:trends*; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000191:economics; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans; D064747:Lansoprazole; D007843:Latin America / Q000453:epidemiology; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage; D054328:Proton Pump Inhibitors / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D013274:Stomach Neoplasms / Q000382:microbiology* / Q000401:mortality / Q000517:prevention & control*
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents; D016568:Drugs, Generic; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D008795:Metronidazole; D000658:Amoxicillin; D017291:Clarithromycin